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Of the 300 or so viruses that cause 
disease in humans, HIV may have the 
greatest adaptive advantage. Like 
most persistent viruses—including 
the herpesviruses Epstein–Barr and 
cytomegalovirus (CMV)—HIV employs 
various strategies to counteract its host’s 
response to infection. But HIV possesses 
a unique ability to sustain a progressive 
attack on the immune system—infecting 
the very cells that coordinate the 
immune response—leaving the body 
susceptible even to normally harmless 
microorganisms. It is these so-called 
opportunistic infections, rather than the 
human immunodeﬁ  ciency virus itself, 
that makes HIV so deadly. The speciﬁ  c 
mechanisms that engineer this ongoing 
systemic attack have been the subject of 
intense research.
HIV targets white blood cells with 
protein surface receptors called CD4. 
These CD4, or helper, T-cells normally 
orchestrate the body’s immune response 
by signaling killer T-cells (which are also 
called CD8 T-cells, after their CD8 surface 
receptors) and other immune cells to 
multiply and differentiate—that is, 
become specially equipped to recognize 
a particular pathogen, or antigen. At 
the onset of infection, the immune 
system appears to respond normally, 
with a strong attack led by HIV-speciﬁ  c 
CD8 T-cells that initially contain the 
virus. But as the infection progresses, 
CD4 counts drop and the body’s ability 
to renew T-cells decreases while its 
proportion of “antigen-experienced’’ 
CD8 T-cells increases. While the 
biological effect of this hyperactivity is 
unclear, it is apparent that patients with 
elevated immune activity face a poor 
prognosis. Investigating the interaction 
among immune activation, CD8 T-cell 
differentiation, and HIV prognosis, Victor 
Appay and colleagues report that a close 
connection between elevated immune 
activation and elevated levels of highly 
differentiated T-cells may bring further 
insights into how HIV exhausts the 
immune system.
To examine the effect of elevated 
immune activation on T-cells, the 
researchers analyzed T-cells from a group 
of HIV-infected individuals collected at 
two distinct points in time: at the onset of 
acute infection—which is characterized 
by vigorous HIV replication—and after 
treatment, when viral replication is 
suppressed. To explore the connection 
between T-cell differentiation and 
clinical status, the researchers analyzed 
the T-cells from a group of untreated 
infected individuals divided into three 
subsets based on stage of infection: 
acute infection, chronic infection without 
progression, and chronic infection with 
signs of progression.
During acute HIV infection, the vast 
majority (80%–90%) of the CD8 T-cell 
population was activated—not just the 
HIV-speciﬁ  c CD8 T-cells. Surprisingly, CD8 
T-cells speciﬁ  c to the Epstein–Barr and 
CMV viruses showed signiﬁ  cant activation 
levels during acute infection, suggesting 
that HIV may indirectly promote the 
replication of these viruses. When the 
researchers investigated the effects of 
this activation on T-cell differentiation, 
they found a correlation between 
increasing antigen concentrations and 
increasing CD8 T-cell activation and 
proliferation. And when Laura Papagno 
et al. analyzed the differentiation state 
of CD8 T-cells in individuals at different 
stages of infection, they found a 
progression in the proportion of highly 
differentiated CD8 T-cells associated with 
HIV disease progression.
These results, the researchers conclude, 
show that chronic overactivation of the 
immune system during HIV infection 
produces the large pool of highly 
differentiated T-cells observed in HIV 
infection. T-cells go through various 
stages toward late differentiation, and 
it may be that the early-differentiated 
CD8 T-cells, which maintain the ability to 
proliferate, offer protective immunity. But 
highly differentiated cells, they propose, 
exhibit characteristics associated with 
“replicative senescence’’—they are in 
effect old, worn-out cells that can no 
longer proliferate. Though replicative 
senescence is a natural process for 
most cells, in the context of HIV—in 
which infected individuals also lose the 
ability to replenish T-cells—it creates an 
aging population of T-cells that are less 
effective at ﬁ  ghting infection.
Papagno L, Spina CA, Marchant A, Salio M, 
Rufer N, et al. (2004) Immune activation 
and CD8+ T-cell differentiation towards 
senescence in HIV-1 infection. DOI: 
10.1371/journal.pbio.0020020
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Two T-cells, one of which recognizes 
a target cell
Late-stage cancers are notoriously 
unresponsive to treatment, making 
certain hard-to-detect cancers 
particularly insidious. Ovarian cancer, for 
example, most often escapes diagnosis 
until the tumor has already metastasized. 
At this stage, ovarian cancer is classiﬁ  ed 
as peritoneal carcinomatosis, a terminal 
condition characterized by widespread 
tumor growth throughout the 
peritoneum, the large serous membrane 
that lines the abdominal cavity, pelvis, 
and associated organs. Advanced cases 
of peritoneal carcinomatosis are largely 
resistant to chemotherapy and account 
for the bleak 15%–20% survival rate of 
ovarian cancer.
Biologists often view cancer as an 
evolutionary process in which cells that 
would normally cooperate with their 
neighbors begin to compete with them. 
Selective advantage for cancer cells 
often begins with mutations that inhibit 
tumor suppressor pathways. p53, like 
other tumor suppressor genes, arrests 
cell growth and induces apoptosis 
(programmed cell death) in response 
to cellular stress, such as chromosomal 
damage. Cells with p53 mutations often 
escape these constraints, leading to 
the uncontrolled growth characteristic 
of “immortal’’ cancer cells. Nearly all 
types of tumors have mutations in the 
p53 pathway. Treatments focused on 
restoring p53 function—which is likely 
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to be defective 
only in cancer 
cells—should 
prove more 
effective than 
chemotherapies, 
which 
indiscriminately 
kill all dividing 
cells, healthy 
or cancerous. 
With the goal of 
developing targeted therapeutic strategies, Steven Dowdy and 
colleagues show that restoring p53 protein function in tumor 
cells not only dramatically increases lifespan in mice but also 
eliminates disease.
While past efforts to restore tumor suppressor function in 
cancer cells have focused on gene therapy, Dowdy and colleagues 
introduced modiﬁ  ed p53 peptides, or protein fragments, into 
cancer cells. p53 works as a “transcriptional’’ activator that binds 
to speciﬁ  c sequences of DNA and triggers apoptosis in response 
to DNA damage. Its biological function ﬂ  ows from this binding 
ability. One region of this large protein, called the C-terminal 
domain, facilitates effective binding. In cancer cells, synthesized 
peptides (called p53C′) derived from this region can induce 
apoptosis by activating p53—which is normally present in low 
levels in a biologically inactive form—and restoring function to 
p53 proteins with DNA-binding mutations.
To get p53C′ peptides into cancer cells, Eric Snyder et al. used a 
technique pioneered by Dowdy that delivers large proteins into 
the cell interior. Since the cell membrane normally limits passage 
to only small molecules (larger molecules generally enter 
through surface receptors), this is no small feat. The technique 
exploits the ability of a small peptide region from the HIV TAT 
protein to smuggle macromolecules through cell membranes 
that normally prohibit entry to such large molecules. After 
synthesizing a structurally modiﬁ  ed form of p53C′ less prone 
to degradation, the researchers ﬁ  rst conﬁ  rmed that the peptide 
was functional and then that it activates p53-speciﬁ  c genes in 
tumor cells, but not in normal cells. Testing the effectiveness of 
the peptide therapy on mouse strains used to model human 
metastatic disease, they found that mice treated with the 
TATp53C′ peptide showed a signiﬁ  cant reduction in tumor 
growth and lived six times longer than both mice treated with a 
control peptide and untreated mice, with some mice remaining 
disease-free more than 200 days after treatment.
This macromolecular delivery approach, Snyder et al. argue, 
works with greater speciﬁ  city and avoids the tumor-generated 
neutralizing effects observed in small molecule strategies. 
Because a mutation in the p53 gene is one of the most common 
events in the development of cancer, these results could have 
implications for a wide variety of cancers. And by working 
with mouse models that approximate the physiological 
burdens metastatic cancer imposes on humans, Dowdy’s team 
demonstrates the promise of developing targeted “intracellular 
biologic’’ therapeutics that treat the systemic pathology of 
cancer—inhibiting tumor growth as well as alleviating the lethal 
complications associated with the disease.
Snyder EL, Meade BR, Saenz CC, Dowdy SF (2004) Treatment of 
terminal peritoneal carcinomatosis by a transducible p53-activating 
peptide. DOI: 10.1371/journal.pbio.0020036
A New Breast Cancer Model 
Thanks to the tools of molecular biology, our understanding of 
the 100-plus diseases known collectively as cancer has increased 
dramatically over the past decades. While each of these cancers 
exhibits unique characteristics reﬂ  ecting the particular cell or 
tissue it springs from, the disease follows a similar arc in nearly all 
its forms. Cancer is a multistep disease that begins when genetic 
damage—initiated by a multitude of agents—unleashes a single 
cell from the normal constraints on cellular proliferation. This 
single transformed cell generates a colony of similarly abnormal 
progeny that can take decades to develop into malignancies.
While events that stimulate uncontrolled cell division can 
promote cancer, mutations in tumor suppressor genes ﬁ  gure 
prominently in tumor progression. Disruptions in the pRb 
(retinoblastoma 1) tumor suppressor, for example, are often seen 
early in cancer development, sensitizing cells to tumorigenesis. 
pRb, along with other “pocket proteins’’—so-called because they 
share an amino acid domain called the Rb pocket—regulate 
cell cycle progression, apoptosis (programmed cell death), and 
cellular differentiation. Some tumor suppressors, such as p53, can 
trigger apoptosis, ultimately sacriﬁ  cing cells that have sustained 
DNA damage or other types of cellular stress.
Mutations in both the pRb and p53 tumor suppressor 
pathways are commonly seen in human cancers, though their 
interactions appear to vary depending on the tissue. In mouse 
brain epithelial cells, for example, loss of p53 function coupled 
with loss of pRb results in reduced apoptosis and increased 
tumor growth, while p53 loss in mouse brain astrocytes (cells 
that support neurons) does not affect tumor growth. Building 
on this work, Terry Van Dyke and colleagues report that loss of 
the pRb tumor suppressor in mammary tissue has the same 
effect—predisposition to tumor formation—seen in these other 
cell types. Despite the different environment inherent in each cell 
type, the initial events following loss of the pRb pathway were 
the same: increased proliferation and apoptosis, followed by 
tumorigenesis. But, surprisingly, pRb and p53 interactions varied 
in different cell types.
Like most cancers, mammary gland cancer has a long latency 
period, prompting the researchers to ask what events engineer 
tumor progression. To investigate the relative contribution of 
pRb and p53 in tumorigenesis, the researchers generated a novel 
mouse model with a dysfunctional pRb pathway and various 
levels of p53 function in several cell types. This is a signiﬁ  cant 
achievement in itself, as many agents that inactivate the pRb 
pathway also disrupt the p53 pathway. pRb inactivation, they 
show, causes abnormalities in mammary cell proliferation, 
apoptosis, and tissue morphology. In these mammary-speciﬁ  c 
pRb-deﬁ  cient mice, p53 was responsible for most of the 
apoptotic response—decreased levels of p53 resulted in reduced 
Transgene expression is associated with increased cell proliferation 
and cell death (apoptosis)
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Gene Expression Signature of a Fibroblast Serum Response Predicts Cancer Progression 
The idea that cancer cells go through a fateful transition 
that turns them into fast-growing, invasive, metastasizing 
tumors ﬁ  rst surfaced in the early 1970s. During this conversion, 
blood vessels form around the tumor, providing a dedicated 
supply of blood to fuel the tumor’s aggressive behavior. By the 
mid-1980s histological analysis revealed a similarity between 
the tumor “microenvironment’’ and that of a healing wound, 
prompting Harvard pathologist Harold Dvorak to describe 
cancer as a wound that does not heal. When the body sustains 
a wound, it coordinates an emergency response deﬁ  ned by 
rapid cell proliferation, invasion and “remodeling’’ of connective 
tissues and extracellular matrix (the network of proteins and 
molecules around cells), cell migration, and blood vessel 
formation (angiogenesis). These processes, which are restorative 
in normal wound healing, may promote cancer by supporting 
tumor formation, invasion, and metastasis. With no systematic 
method to measure the “wound-like’’ features in cancer, however, 
scientists have no way to evaluate the risk that a wound-healing 
genetic program may pose in cancer progression.
A molecular understanding of the wound-healing process and 
its connection to cancer would provide insight into the nature 
of these similarities and perhaps provide molecular indicators 
of tumor progression. In an effort to create a framework for 
evaluating this relationship, Howard Chang and his colleagues 
at Stanford University developed a model to predict cancer 
progression based on the gene expression proﬁ  le of a cellular 
response to serum in cell culture.
Part of the problem with evaluating the physiological status 
of a tumor based on its genetic proﬁ  le is that current techniques 
indicate only the expression, not the effect, of genes. To develop 
a strategy for interpreting biological outcomes from a gene 
expression proﬁ  le, Brown’s team modeled a physiological 
process by exposing cultured ﬁ  broblasts to serum—the soluble 
fraction of coagulated blood—and tracking gene expression. 
Serum is encountered in the body where blood leaks out of 
blood vessels (in essence, all the sites of injury) and is thought 
to be a major initiator of the wound response. Fibroblasts exist 
in the connective tissue of epithelial organs (which include the 
digestive tract, lungs, and mammary glands) and contribute 
to organ development, wound healing, inﬂ  ammation, and a 
condition called ﬁ  brosis. (Fibrosis involves the same type of 
extracellular matrix remodeling seen in wound healing and 
cancer.) And ﬁ  broblasts can promote tumor formation and 
metastasis when mixed with epithelial cancer cells.
Though ﬁ  broblasts from different sites in the body differ in 
their properties and gene expression proﬁ  les, Chang et al. found 
that they share a common expression pattern in response to 
serum. From this expression proﬁ  le, the researchers identiﬁ  ed 
a core group of genes—a genetic signature—associated 
with a serum response. Because many of the genes in the 
signature were known to be involved in various wound-healing 
processes—such as matrix remodeling, cell motility, and 
angiogenesis—Chang 
et al. used this signature 
as a surrogate marker 
to measure how much 
tumors may be like 
wounds. When they 
compared the wound-
like genetic signature 
with the expression 
proﬁ  les of various clinical 
tumor samples, they 
found the signature was 
always present in certain 
cancers—prostate and 
liver-cell carcinomas—and 
occurred variably in others—breast, lung, and gastric carcinomas. 
In each of these three latter types of tumors, patients with tumors 
carrying the serum-activated wound-like genetic signature had a 
signiﬁ  cantly increased risk of metastasis and death compared to 
patients with tumors that lacked the signature. Therefore, Chang 
et al. conclude that a wound-like phenotype is a general risk 
factor for metastasis and the aggressive behavior in many of the 
most common cancers.
These results reveal a robust and useful similarity between 
the molecular programs in normal wound healing and tumor 
progression and metastasis. Although Chang et al. point out that 
their results do not indicate whether this ﬁ  broblast “ﬁ  ngerprint’’ 
is merely a marker for cancer progression or plays a role in 
orchestrating this pathway, they conclude that the genetic 
program activated in response to serum also contributes to 
tumor invasion and metastasis. This serum-response expression 
proﬁ  le, the authors propose, provides a valuable new tool 
for predicting tumor behavior and determining a patient’s 
prognosis.
Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, et al. (2004) 
Gene expression signature of ﬁ  broblast serum response predicts 
human cancer progression: Similarities between tumors and wounds. 
DOI: 10.1371/journal.pbio.0020007
apoptosis and accelerated tumorigenesis, 
but had no effect on proliferation. 
Interestingly, in other mouse models 
where aberrant proliferation is caused by 
disabling other pathways, loss of p53 was 
associated with increased proliferation—
rather than reduced apoptosis—and 
early tumor formation. And while p53 is 
the main effector of apoptosis in brain 
and mammary epithelial cells, this is not 
the case in all tissues: in astrocytes, for 
example, the tumor suppressor Pten 
regulates apoptosis in response to pRb 
inactivation. Together these results 
indicate that speciﬁ  c cellular responses 
to a cancer-causing stimulus vary 
depending on the nature of the initial 
genetic injury and the cell type and that 
pRb and p53 interact in different ways 
in different tissues. And p53, it appears, 
contributes to tumor suppression—and 
thus progression—through multiple 
mechanisms.
By creating a mouse model that 
disentangles the pRb and p53 pathways, 
Van Dyke and colleagues have added 
a valuable resource for studying breast 
cancer. This model, they propose, will 
facilitate further investigations into 
the relative contributions of these 
overlapping pathways to cancer 
progression. What’s more, the model 
offers a vehicle for examining how 
pRb interacts with other breast cancer 
mutations, like the inherited mutations 
in the human BRCA1 and BRCA2 genes, 
to shed light on the complex series 
of events that ultimately cause breast 
cancer.
Simin K, Wu H, Lu L, Pinkel D, Albertson 
D, et al. (2004) pRb inactivation in 
mammary cells reveals common mechanisms 
for tumor initiation and progression 
in divergent epithelia. DOI: 10.1371/
journal.pbio.0020022
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Most animals (including humans) 
show a high level of bilateral symmetry: 
on the surface, the right side of our body 
resembles the left. A closer and deeper 
look, however, reveals an underlying 
asymmetry. The heart, for example, is on 
the left side in most humans, and the liver 
on the right. This left-right asymmetry 
develops early on in the embryo, and 
research in the past few years has 
revealed some of the molecular and 
cellular mechanisms that establish the 
left-right axis, which conveys positional 
information to cells in the growing 
embryo. We know that the formation 
of the axis relies on “crosstalk’’ between 
cells, which involves long-range signaling 
molecules (or ligands) and cell-surface 
receptors on cells that receive the signal.
The molecules involved in the 
formation of the left-right axis during 
embryogenesis, along with their 
functions, are conserved among 
vertebrates. They include members of 
the Transforming Growth Factor beta 
(TGF-β) family—such as the agonists (or 
ligands) Nodal, Vg1/GDF, and activin, and 
the antagonist (a molecule that interferes 
with agonist/ligands) Lefty—on the 
signaling side and members of the EGF-
CFC family—such as the activin receptor 
and its coreceptors—on the receiving 
side. The EGF-CFC proteins play important 
roles in early vertebrate embryogenesis; 
mutations in these genes in the 
zebraﬁ  sh (and mouse) result in a range 
of developmental defects, including 
problems in left-right axis speciﬁ  cation. 
While ligand-stimulation of the activin 
receptor by Nodal and Vg1/GDF requires 
the EGF-CFC coreceptors, activin can 
activate the activin pathway without a 
coreceptor. Lefty—being an antagonist—
can block activation of the activin 
receptor, though it is not clear how.
Through genetic and biochemical 
studies in zebraﬁ  sh and frog embryos, 
Simon Cheng, Alex Schier, and 
colleagues have now clariﬁ  ed a piece 
of this very complex signaling puzzle 
by demonstrating that Lefty inhibits a 
subset of TGF-β signals—Nodal and Vg1/
GDF but not activin—by blocking EGF-
CFC coreceptors. They went on to show 
that a short, speciﬁ  c region of the signal 
molecules—accounting for less than 
4% of the entire protein—determines 
whether the signals activate the activin 
receptor in an EGF-CFC coreceptor-
dependent or -independent fashion 
and therefore governs susceptibility to 
Lefty. These ﬁ  ndings suggest that subtle 
sequence differences between related 
signals can dramatically inﬂ  uence their 
function.
Gene families are thought to arise 
from gene duplications, and the studies 
described here illustrate how members 
of the same gene families can gain 
diverse roles by speciﬁ  c interactions with 
coreceptors and antagonists. Additional 
studies will be necessary to reveal the 
structural basis for the observed diversity.
Cheng SK, Olale F, Brivanlou AH, 
Schier AF (2004) Lefty blocks a subset of 
TGFβ signals by antagonizing 
EGF-CFC coreceptors. DOI: 10.1371/
journal.pbio.0020030
Faced with new and ongoing threats to public health, 
researchers are becoming increasingly resourceful in their quest 
to discover new drugs. Drug researchers have long looked to 
living organisms for inspiration, either mimicking or extracting 
chemical formulas from naturally occurring compounds. Bacteria 
and fungi, for example, produce a wide range of compounds—
some of which give them a selective 
advantage in their own environments—
that provide important pharmaceutical 
activities. One class of these natural 
compounds are the polyketides, which 
make up a large portion of the antibiotics 
(including erythromycin and tetracycline) 
and antitumor drugs (such as doxorubicin 
and epothilone) that have been isolated 
from various microorganisms.
Polyketides are synthesized by bacteria 
and fungi by the appropriately named 
polyketide synthases (PKSs). PKSs can 
be thought of as large molecular factories containing a series 
of enzymes working on an assembly line: each enzyme in the 
line adds molecules to a primer, or starter, unit—which is usually 
an acetate molecule—and then hands off the growing chain to 
the next enzyme. The speciﬁ  c enzymes set all the characteristics 
of the polyketide, including the chain length, the building 
blocks used, and the branching pattern of the molecules. 
Although microorganisms generate polyketides with a variety of 
characteristics, one goal of drug discovery research is to increase 
this diversity even further—a larger pool of polyketides promises 
more drugs with enhanced pharmaceutical applications.
Early attempts at creating artiﬁ  cial polyketides focused on 
altering the functional characteristics of naturally occurring 
polyketides—the length of the chain, the building blocks, and 
the patterns of the branches. Chaitan Khosla and colleagues 
have taken this approach one very large step further. Rather 
than changing the machinery to modify the growing structure 
of a polyketide, they engineered bacteria 
to use an alternative, nonacetate primer 
molecule. This has important practical 
implications because some medicinally 
signiﬁ  cant compounds do not use the 
usual acetate primer unit. By dissecting out 
the speciﬁ  cities of the “starter’’ and longer, 
multiunit “elongation’’ PKS enzymes and by 
mixing and matching modules, they have 
produced novel polyketide analogs (in this 
case, of anthraquinone) with more effective 
medically relevant properties. One of the 
compounds they engineered shows enhanced 
efﬁ  cacy in blocking the growth of breast cancer cells that 
depend on the activity of the estrogen receptor, while a second 
polyketide inhibits an enzyme linked to adult-onset diabetes, 
demonstrating just two possible new therapeutic applications 
for synthesized polyketides. But, as the authors propose, this 
method promises to reveal new pharmaceutical agents that 
haven’t even been discovered yet.
Tang Y, Lee TS, Khosla C (2004) Engineered biosynthesis of 
regioselectively modiﬁ  ed aromatic polyketides using bimodular 
polyketide synthases. DOI: 10.1371/journal.pbio.0020031
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Comparing the Networks that Power Bacterial Chemotaxis
When we think of foraging for food, we usually imagine animals wandering in the 
woods, poking behind bushes and trees, trying to ﬁ  nd something tasty. Amazingly, even 
single-cell bacteria display a simpliﬁ  ed version of this behavior. Many species of bacteria 
can respond to chemical or nutritional cues (chemoattractants) in the environment 
by moving toward locations with more favorable conditions, a process known as 
chemotaxis. The bacteria adjust their movements by rotating threadlike projections 
called ﬂ  agella either clockwise or counterclockwise; these adjustments are made by a 
network of proteins in response to chemoattractants. Chemotaxis has been identiﬁ  ed in 
many bacterial species, but two of the best-studied examples are in Escherichia coli and 
Bacillus subtilis. Computer modeling of chemotaxis in these species now reveals some 
important differences in the network architecture that controls this complex behavior.
Most of the proteins involved in chemotaxis in E. coli and B. subtilis have been 
identiﬁ  ed and well studied, but much remains to be learned about this biological 
process. As scientists have begun to understand how the proteins work together, they’re 
discovering a network of interactions that operates a bit like an electronic circuit. 
Researchers have found that using the circuit as a model for protein networks has 
helped them to understand how complex system properties arise from seemingly simple 
interactions between proteins. These 
properties can be explored with the 
aid of computer simulations, whereby 
researchers can rapidly test a given 
system under many different situations 
and can tweak the properties of the 
proteins and their connections.
The team, led by Adam Arkin of the 
University of California at Berkeley, has 
compared the system level properties 
of chemotaxis in the two bacterial 
species E. coli and B. subtilis. Not 
surprisingly, the proteins involved in 
the signaling pathway are conserved—
that is, they have changed very little 
since they ﬁ  rst evolved—even though 
these species are evolutionarily very distant. In many cases, a gene from one species 
can even substitute for the ortholog (a conserved gene that retains the same function 
even though two species have diverged) in the other. Despite these similarities, however, 
disrupting the function of orthologous genes in these two species often has different, 
even opposite, effects. This is surprising, especially given that the chemotactic behaviors 
of E. coli and B. subtilis are almost identical. In order to understand this puzzling 
observation, the researchers constructed a network model of the chemotaxis system in 
B. subtilis and used simulations to understand how the network properties differ from 
those of existing models of E. coli chemotaxis.
The group found that despite the similarities in proteins and the nearly identical 
behavior between the two species, the mechanisms underlying the behavior are quite 
distinctive. When comparing the system properties of these two bacterial systems, the 
researchers also made an unusual observation. Though the two “circuits’’ have different 
wiring, the system properties underlying the behavior, called the control strategy, are 
very similar. The two species of bacteria therefore achieve the same chemotaxis behavior 
by using similar proteins, but in different ways.
Arkin and colleagues draw two important conclusions from these results. First, these 
two systems have conserved proteins, but the proteins are wired together differently. 
This means that wiring of signaling networks cannot be inferred simply by identifying 
the conserved proteins in the network. Second, in these systems, conserved proteins use 
different mechanisms to accomplish the same overall control strategy. This raises the 
question of how such systems evolve. The authors suggest that the control strategy itself 
may be an evolutionarily conserved property. These conclusions will be important to 
keep in mind as researchers examine these systems in more detail and begin to examine 
more complex systems as well.
Rao CV, Kirby JR, Arkin AP (2004) Design and diversity in bacterial chemotaxis: A 
comparative study in Escherichia coli and Bacillus subtilis. DOI: 10.1371/journal.pbio.0020049
Modeling chemotaxis
Mutation Rates and Gene 
Location: Some Like It Hot 
The growing library of sequenced 
genomes is challenging scientists to 
extract new biological meaning from 
DNA sequences. Comparative analysis 
of the mouse and human genome, 
for example, has already revealed that 
mutation rates in the 3 billion base pairs 
of the human genome vary considerably. 
What accounts for this regional disparity, 
however, is unclear. Mutations—
substitutions in the nucleotide bases of 
DNA—produce variation in the genome. 
In classical evolutionary theory, natural 
selection drives evolutionary change by 
determining which of these mutations 
live on in the next generation or die 
with the organism. Mutations can be 
neutral, harmful, or beneﬁ  cial, though the 
neutral theory of molecular evolution 
predicts that most mutations are “nearly’’ 
neutral or only slightly deleterious, while 
beneﬁ  cial mutations—which confer a 
survival advantage on an organism and, if 
it reproduces, on its progeny—are quite 
rare. As a whole, mutations occur at the 
rate of approximately ﬁ  ve substitutions 
per billion nucleotide sites per year.
There are many types of neutral 
mutations—that is, mutations that 
have no effect on function. DNA base 
substitutions that lie outside of gene-
coding regions or occur within introns 
(regions that are excised before being 
translated into a protein sequence) can 
fall into this category. Neutral mutations 
can also occur within gene-coding 
regions. For example, there are many 
instances where more than one codon—
say, CUU, CUC, CUA, CUG—specify the 
same amino acid—in this case, leucine. 
Since these mutations can be used to 
gauge the neutral mutation rate of a 
region in the genome, they can be used 
to analyze the relationship between 
local mutation rates and gene location. 
Correlating gene mutation rates with 
their location in the genome, Jeffrey 
Chuang and Hao Li not only conﬁ  rm that 
regional mutation rates indeed exist, but 
also calculate the size of these regions. 
Strikingly, certain classes of genes tend to 
congregate in mutational “hot spots’’—
regions with high mutation rates—while 
other types of genes gravitate toward 
“cold spots’’—regions with relatively low 
mutation rates.
Chuang and Li ﬁ  rst determined 
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If you’ve ever hit a patch of ice on the road that sent your car 
swerving left while you resolutely—and futilely—steered right 
to get back in your lane, you’ve experienced what neuroscientists 
call a “visuomotor rotation task.’’ On a dry road, your response 
would have been appropriate. But under icy conditions, the same 
sensory cue produces a decidedly negative result: a car ﬁ  shtailing 
out of control. While you’re ﬁ  guring out what movements 
will straighten out the car, the neurons in your primary motor 
cortex—the region of the brain responsible for movement—are 
taking notes. Chances are, your next icy encounter was less 
dramatic. But how does your brain learn to produce a different 
movement in response to the same visual cue?
Neuroscientists investigate such questions by recording and 
analyzing the electrical activity of neurons during learning 
and performance of new sensory-motor transformations. Such 
studies, for example, show that populations of neurons in 
different brain areas map sensory cues and desired arm motion 
by creating an internal representation of the corresponding 
sensory and motor coordinates in a way that allows ﬂ  exible 
responses to changing conditions. In previous studies, Rony Paz 
and Eilon Vaadia, of The Hebrew University in Israel, found that 
neurons in the primary motor cortex that ﬁ  re before monkeys 
move their arm in a particular direction have higher ﬁ  ring rates 
after the monkey learns to dissociate the arm direction from the 
cursor direction (an indicator of visual feedback). Interestingly, 
changes in activity preferentially occurred in a subset of neurons 
that were already tuned (that is, maximally activated during 
movement) to the direction experienced while learning.
While many studies indicate that learning new tasks can 
generate speciﬁ  c changes in brain activity, it had not been clear 
how or if such changes improve the internal representation 
inside the brain. Speciﬁ  cally, is the neuronal code any “better’’ 
after learning? Now Paz and Vaadia show that while these 
neurons are ﬁ  ring at higher rates they are also transmitting more 
information about speciﬁ  c task parameters.
Paz and Vaadia trained two rhesus monkeys to learn various 
visual-motor tasks—which involved operating a joystick to 
move a cursor on a screen—and then changed the relationship 
between the visual feedback (the cursor) and hand movement. 
Using information-theory analysis—which measures the 
amount of information that single neurons can tell about the 
biases—that is, whether the frequency 
and distribution of mutations follow a 
distinct pattern along the genome. The 
researchers calculated the substitution 
rates of neutral mutations in nearly 
15,000 orthologous mouse and human 
genes—orthologous genes are genes 
that have evolved from a common 
ancestor without diverging in biological 
function—and found that mutation 
rates were in fact skewed toward either 
high or low rates. Mutation rate analysis 
of the orthologs’ neighbors revealed 
rates similarly skewed toward high or 
low substitutions, indicating that the 
region itself, rather than a 
particular gene, is prone to 
these differential rates. These 
regions, Chuang and Li report, 
were either one megabase or 
ten megabases long, affecting 
up to roughly 100 genes.
But the question remained: 
Does the organism take 
advantage of these mutational 
hot and cold spots? If there 
is an adaptive advantage, 
gene families should occur 
in an appropriate mutational 
zone. In mutational hot spots, 
for example, one would expect to ﬁ  nd 
genes that would beneﬁ  t from high 
rates of mutation, which would in turn 
facilitate ﬂ  exible responses to constantly 
changing environmental stimuli. Likewise, 
one would expect genes in cold regions 
to need protection from potentially 
deleterious mutations. And that’s just what 
Chuang and Li found. Overall, genes in 
hot regions code for proteins involved in 
cell signaling, such as olfactory receptors, 
G-protein coupled receptors, membrane 
proteins, and immune response 
proteins—being in an area subject to 
high mutation rates means these genes 
can evolve quickly enough to adapt to 
constantly changing stimuli. Cold-region 
genes code for “housekeeping’’ proteins 
involved in core cellular processes, like 
transcription regulation and protein 
modiﬁ  cation—these genes tend to be 
highly conserved, changing very little 
since they ﬁ  rst evolved.
Thus, it appears that natural selection 
may also operate at the level of gene 
location, relegating genes to different 
mutational genomic niches according 
to their function. While Chuang and Li 
explore possible mechanisms to account 
for these genomic niches—such as gene 
duplication and gene transposition—
they argue that the selective pressures 
that inﬂ  uence gene location are the same 
that inﬂ  uence mutations in genes. By 
calculating the sizes of these mutational 
hot and cold regions, the researchers lay 
the groundwork for investigating genetic 
mechanisms that operate on these scales. 
And by showing that location matters, 
they have revealed a new force in 
genome evolution.
Chuang JH, Li H (2004) Functional bias and 
spatial organization of genes in mutational 
hot and cold regions in the human genome. 
DOI: 10.1371/journal.pbio.0020029
Olfactory genes lie in a mutational “hot spot”
When Monkeys Learn Directional Tasks, Neurons Learn Too
Mutual information between neuronal activity and direction 
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The primate brain processes a remarkably diverse array of 
visual cues to recognize objects in dynamic settings crammed 
with unfamiliar objects. Not surprisingly, repeated viewing aids 
recognition, but how the brain orchestrates this experience-
driven improvement is unclear. Visual input to the brain travels 
from the eye to the primary visual cortex (V1), at the back of the 
brain. From there, signals are sent to nearby extrastriate cortical 
areas, which process “early’’ visual cues. Both the “lower level’’ 
extrastriate cortex and “higher level’’ inferior temporal (IT) cortex 
are important for object recognition in primates. In monkeys and 
humans, lesions 
in the IT cortex 
severely affect the 
ability to recognize 
objects.
In these 
higher-level 
cortical regions, 
neurons carry 
more information 
about an object 
after subjects learn 
to recognize that 
object. This modiﬁ  ed neural activity is thought to reﬂ  ect internal 
representations of speciﬁ  c aspects of the learned task—such 
as learned recognition of three-dimensional objects—and 
these representations often remain stable even though 
certain features of the visual stimulus—such as size or image 
degradation—change. With recent evidence suggesting that 
lower level brain regions like the primary visual cortex are also 
capable of learning-related modiﬁ  cations, it appears that both 
early and higher brain areas of the “ventral visual stream’’ beneﬁ  t 
from learning. It is not clear, however, how learning modiﬁ  es 
these discrete brain regions to coordinate this processing.
By training monkeys to recognize degraded images, Gregor 
Rainer, Han Lee, and Nikos Logothetis of the Max Planck 
Institute for Biological Cybernetics in Germany have identiﬁ  ed 
a subset of neurons that compensate for indistinct visual 
inputs by coordinating disparate regions in the brain. The 
monkeys’ improved performance, they propose, stems from the 
informational enrichment of a subset of lower level neurons. 
Along with an increase in learning-induced ﬁ  ring activity, V4 
neurons—extrastriate cortical neurons associated with detecting 
visual input of intermediate complexity—encode more 
information about relevant details to resolve indeterminate 
visual cues. V4 neurons likely interact with higher cortical levels 
to help the monkeys interpret the degraded indeterminate 
images as something recognizable.
The researchers presented the monkeys with different 
“natural’’ images, including pictures of birds and humans, 
then subjected the images to different levels of “stimulus 
degradation’’—making them harder to read by adding varying 
amounts of visual 
noise. Using 
this approach, 
the researchers 
could record the 
activity of the V4 
neurons as the 
monkeys were 
presented with the 
different images. 
The monkeys 
viewed a sample 
image and then 
signaled whether a second image, presented after a brief delay, 
was a match or not. When Rainer et al. analyzed the activity of 
the V4 neurons associated with the different images, they found 
there was no signiﬁ  cant change in the activity or information 
conveyed by V4 neurons associated with novel or undegraded 
familiar images. On the other hand, learning not only signiﬁ  cantly 
improved the monkeys’ ability to recognize degraded stimuli but 
also increased both the activity and informational encoding of 
the V4 neurons.
But how did individual V4 neurons facilitate this enhanced 
ability to recognize degraded stimuli? After identifying a subset 
of neurons that showed enriched neural activity in response 
to degraded or indeterminate stimuli, the researchers studied 
the monkeys’ eye movements to determine any behaviors that 
might explain why monkeys performed better with familiar 
degraded stimuli. They mapped the monkeys’ eye movements 
while allowing them to freely view the different familiar and 
novel images—but this time with just two coherence levels 
(undegraded and 45% coherent). There was substantially more 
Learning to Discern Images Modiﬁ  es Neural Activity
Monkeys can learn to recognize degraded images
movement—they were able to correlate 
neuron activity with direction of 
movement and, conversely, distinguish 
differences between directions based 
on neuron activity. Their analysis 
revealed that the neurons transmit 
more information about the direction 
of movement after the monkeys learn 
a task. To ﬁ  gure out what aspect of 
neuron activity conveys this improved 
information, Paz and Vaadia examined 
two features of neuron signaling—
response variability and directional 
sensitivity—which they reasoned might 
plausibly accomplish this. Increased 
information content after learning a task, 
they found, corresponded to sensitivity to 
a single direction, and neurons attuned to 
that direction contributed to the increase.
These ﬁ  ndings suggest that subsets 
of directionally sensitive neurons 
increase their ﬁ  ring rates to more ﬁ  nely 
tune their sensitivity to that direction. 
By successfully reconstructing the 
movement direction from the neuron 
signals captured after learning a task, 
Paz and Vaadia also demonstrate that 
the observed learning improvement can 
be extracted to predict behavior. The 
authors argue that their results suggest a 
close association between properties of 
neurons—such as directional tuning of 
cells—and learning a skill that is focused 
on the same parameter—in this case, 
direction. Together with results from 
visual and auditory areas, they propose 
that similar mechanisms may control the 
interplay between neurons and learning 
throughout the central nervous system.
Paz R, Vaadia E (2004) Learning-induced 
improvement in encoding and decoding of 
speciﬁ  c movement directions by neurons in 
the primary motor cortex. DOI: 10.1371/
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overlap, in terms of where the monkeys looked for the 45% 
and 100% coherent images after learning. This suggests that 
monkeys learned to focus their attention on particular salient 
features, and were thus better able to identify degraded versions 
of these images.
Neurons in the V4 area appear to be recruited to distinguish 
the relevant visual signal from the visual noise, and thus play 
a critical role in resolving indeterminate stimuli when salient 
features are present. These results, together with previous 
studies showing the sensitivity of prefrontal cortex neurons to 
novel stimuli, indicate that the prefrontal cortex processes novel 
stimuli while the V4-rich extrastriate visual areas convey details 
about hard to decipher images. It may be that as the V4 neurons 
reﬁ  ne their competence through learning, they also support the 
ability of the prefrontal cortex to process different but similar 
visual cues. Vision is a dynamic process, Rainer et al. conclude, 
characterized by ongoing interactions between stimulus-driven 
brain regions and feedback from higher-order cognitive regions.
Rainer G, Lee H, Logothetis N (2004) The effect of learning on 
the function of monkey extrastriate visual cortex. DOI: 10.1371/
journal.pbio.0020044